Phosphorus Magnetic Resonance Spectroscopic Imaging (31P-MRSI) Study of Open-Label Creatine for Adolescent Females with SSRI-Resistant Major Depressive Disorder

Friday, October 21, 2011

Douglas G. Kondo, M.D., Department of Psychiatry and The Brain Institute, University of Utah, Salt Lake City, UT

Xianfeng Shi, Ph.D., The Brain Institute, University of Utah, Salt Lake City, UT

Young-Hoon Sung, M.D., Department of Psychiatry and The Brain Institute, University of Utah, Salt Lake City, UT

Kristen K. Fiedler, B.S., The Brain Institute, University of Utah, Salt Lake City, UT

Tracy L. Hellem, R.N., The Brain Institute, University of Utah, Salt Lake City, UT

Rebekah S. Huber, B.A., The Brain Institute, University of Utah, Salt Lake City, UT

Perry F. Renshaw, M.D., M.B.A., Ph.D., Department of Psychiatry and The Brain Institute, University of Utah, Salt Lake City, UT


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 5.50 Phosphorus Magnetic Resonance Spectroscopic Imaging (31P-MRSI) Study of Open-Label Creatine for Adolescent Females with SSRI-Resistant Major Depressive Disorder